San Francisco, California, United States Alector is the famous Corporate Investor, which was founded in 2013. The company was established in North America in United States. The main department of described Corporate Investor is located in the San Francisco.
The standard case for the fund is to invest in rounds with 1 partaker.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight INmuneBIO. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Commercial, Medical.
The current fund was established by Arnon Rosenthal, Asa Abeliovich, Tillman Gerngross.
The higher amount of exits for fund were in 2019. The top activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars.
| Fund Name | Location |
| Ephor Group | Houston, Texas, United States |
| GS Caltex | Seoul, Seoul-t'ukpyolsi, South Korea |
| GSO Business Management | California, Sherman Oaks, United States |
| Health Catalyst | Salt Lake City, United States, Utah |
| Hezhi Capital | China, Guangdong, Shenzhen |
| Leapfrog Ventures | California, Menlo Park, United States |
| Rosalind Capital Partners | Canada, Ontario, Toronto |
| SK Materials | Seoul, Seoul-t'ukpyolsi, South Korea |
| The CoFoundry | Antwerp, Antwerpen, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 